Published in J Interferon Res on January 01, 1983
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods (1989) 9.42
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Conversion of diploidy to haploidy. Nature (2000) 3.28
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer (1997) 2.64
Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A (1975) 2.59
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
Solidarity and equity: new ethical frameworks for genetic databases. Nat Rev Genet (2001) 2.51
The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol (1991) 2.50
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) Circulation (1997) 2.34
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA (1986) 2.08
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose. J Immunol (1973) 1.88
Why ruminators are poor problem solvers: clues from the phenomenology of dysphoric rumination. J Pers Soc Psychol (1999) 1.82
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol (2000) 1.79
5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol (1997) 1.79
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Predicting zygosity in Norwegian twin pairs born 1915-1960. Clin Genet (1983) 1.68
Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67
Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet (1985) 1.66
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta. Am J Hum Genet (1984) 1.62
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
Ethical aspects of medical genetics. A proposal for guidelines in genetic counseling, prenatal diagnosis and screening. Clin Genet (1985) 1.60
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Photochemotherapy of cancer: experimental research. Photochem Photobiol (1992) 1.59
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet (1974) 1.54
Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. Br J Anaesth (1999) 1.53
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem (2000) 1.52
Therapeutic electrical stimulation in cerebral palsy: a randomized, controlled, crossover trial. Dev Med Child Neurol (2001) 1.52
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol (2001) 1.49
Education policy and the heritability of educational attainment. Nature (1985) 1.48
Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet (1993) 1.45
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol Immunother (1992) 1.45
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction. Atherosclerosis (1999) 1.43
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41
Marfan syndrome: exclusion of genetic linkage to the COL1A2 gene. Clin Genet (1986) 1.40
Permanent Committee of the International Congress of Human Genetics. Am J Med Genet (1998) 1.38
Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol Med (1996) 1.38
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res (1997) 1.36
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 1.30
DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet (1989) 1.26
An inherited X-linked serum system in man; the Xm system. J Exp Med (1966) 1.25
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Genetic and environmental contributions to the covariance between occupational status, educational attainment, and IQ: a study of twins. Behav Genet (1989) 1.24
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Finding the gene(s) for alcoholism. JAMA (1990) 1.21
Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads. Biotechniques (1993) 1.21
Lipoprotein(a) and atherosclerosis. Ann Intern Med (1991) 1.21
5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol (2000) 1.20
DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet (1986) 1.20
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet (1994) 1.18
A linkage study of phenylketonuria. Clin Genet (1974) 1.18
In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. Int J Cancer (2001) 1.18
Oxygen cost of running barefoot vs. running shod. Int J Sports Med (2011) 1.18
Linkage between familial hypercholesterolemia with xanthomatosis and the C3 polymorphism confirmed. Cytogenet Cell Genet (1978) 1.17
Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol (1987) 1.17
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Autosomal dominant myopathy: missense mutation (Glu-706 --> Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci U S A (2000) 1.15
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons. J Gen Virol (1975) 1.13
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci U S A (1986) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res (2010) 1.09
Cerebellar ataxia and hypergonadotropic hypogonadism in two kindreds. Chance concurrence, pleiotropism or linkage? Clin Genet (1976) 1.09
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Observations of toxic blue-green algae (Cyanobacteria) in some Scandinavian lakes. Acta Vet Scand (1986) 1.08
Blood groups and genetic serum types in diabetes mellitus. Diabetologia (1967) 1.08
Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol (2005) 1.08
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07
The gene for apolipoprotein C-II is closely linked to the gene for apolipo-protein E on chromosome 19. Clin Genet (1984) 1.07
The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds. Clin Genet (1976) 1.07
A TaqI RFLP at the EDN1 gene locus. Nucleic Acids Res (1990) 1.07
Plasma N-terminal pro-atrial natriuretic peptide predicts death after premature myocardial infarction, but not as well as radionuclide ejection fraction. A ten-year follow-up study. Scand Cardiovasc J (2001) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer (1994) 1.06
Parental determinants of birth weight. Clin Genet (1984) 1.06
Association of parental consanguinity with decreased birth weight and increased rate of early death and congenital malformations. Clin Genet (1985) 1.06